Exact Mass: 358.2719098
Exact Mass Matches: 358.2719098
Found 399 metabolites which its exact mass value is equals to given mass value 358.2719098,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pregnenolone acetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone
11beta-Hydroxy-6alpha,11-dimethylprogesterone
D-Homotestosterone propionate
MG(18:0/0:0/0:0)
MG(18:0/0:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups: 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well. MG(18:0/0:0/0:0), in particular, consists of one chain of stearic acid at the C-1 position. MG(18:0/0:0/0:0 is used as a food additive (EAFUS: Everything Added to Food in the United States). MG(18:0/0:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(18:0/0:0/0:0) is made up of one octadecanoyl(R1).
MG(0:0/18:0/0:0)
MG(0:0/18:0/0:0) is a monoacylglyceride. A monoglyceride, more correctly known as a monoacylglycerol, is a glyceride consisting of one fatty acid chain covalently bonded to a glycerol molecule through an ester linkage. Monoacylglycerol can be broadly divided into two groups; 1-monoacylglycerols (or 3-monoacylglycerols) and 2-monoacylglycerols, depending on the position of the ester bond on the glycerol moiety. Normally the 1-/3-isomers are not distinguished from each other and are termed alpha-monoacylglycerols, while the 2-isomers are beta-monoacylglycerols. Monoacylglycerols are formed biochemically via release of a fatty acid from diacylglycerol by diacylglycerol lipase or hormone sensitive lipase. Monoacylglycerols are broken down by monoacylglycerol lipase. They tend to be minor components only of most plant and animal tissues, and indeed would not be expected to accumulate because their strong detergent properties would have a disruptive effect on membranes. 2-Monoacylglycerols are a major end product of the intestinal digestion of dietary fats in animals via the enzyme pancreatic lipase. They are taken up directly by the intestinal cells and converted to triacylglycerols via the monoacylglycerol pathway before being transported in lymph to the liver. Mono- and Diglycerides are commonly added to commercial food products in small quantities. They act as emulsifiers, helping to mix ingredients such as oil and water that would not otherwise blend well. MG(0:0/18:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(0:0/18:0/0:0) is made up of one octadecanoyl(R2).
MG(i-18:0/0:0/0:0)
MG(i-18:0/0:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(i-18:0/0:0/0:0) is made up of one 16-methylheptadecanoyl(R1).
Kinetensin 1-3
Kinetensin 1-3 is a fraction of kinetensin with only the Ile-Ala-Arg peptide chain. Kinetensin is a nonapeptide, originally isolated from pepsin-treated plasma that shares some sequence homology with the C-terminal end of neurotensin, serum albumin, and angiotensin. It is a potent histamine releaser in rodents and may serve as an inflammatory mediator. Kinetensin 1-3 is a fraction of Kinetensin with only Ile-Ala-Arg peptide chain.
13,14-Dihydro PGF-1a
13,14-Dihydro PGF-1alpha is a prostanoid. Prostanoids is a term that collectively describes prostaglandins, prostacyclines and thromboxanes. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). The reaction product of COX is the unstable endoperoxide prostaglandin H (PGH) that is further transformed into the individual prostanoids by a series of specific prostanoid synthases. Prostanoids are local-acting mediators formed and inactivated within the same or neighbouring cells prior to their release into circulation as inactive metabolites (15-keto- and 13,14-dihydroketo metabolites). Non-enzymatic peroxidation of arachidonic acid and other fatty acids in vivo can result in prostaglandin-like substances isomeric to the COX-derived prostaglandins that are termed isoprostanes. Prostanoids take part in many physiological and pathophysiological processes in practically every organ, tissue and cell, including the vascular, renal, gastrointestinal and reproductive systems. Their activities are mediated through prostanoid-specific receptors and intracellular signalling pathways, whilst their biosynthesis and action are blocked by nonsteroidal antiinflammatory drugs (NSAID). Isoprostanes are considered to be reliable markers of oxidant stress status and have been linked to inflammation, ischaemia-reperfusion, diabetes, cardiovascular disease, reproductive disorders and diabetes. (PMID: 16986207) [HMDB] 13,14-Dihydro PGF-1alpha is a prostanoid. Prostanoids is a term that collectively describes prostaglandins, prostacyclines and thromboxanes. Prostanoids are a subclass of the lipid mediator group known as eicosanoids. They derive from C-20 polyunsaturated fatty acids, mainly dihomo-gamma-linoleic (20:3n-6), arachidonic (20:4n-6), and eicosapentaenoic (20:5n-3) acids, through the action of cyclooxygenases-1 and -2 (COX-1 and COX-2). The reaction product of COX is the unstable endoperoxide prostaglandin H (PGH) that is further transformed into the individual prostanoids by a series of specific prostanoid synthases. Prostanoids are local-acting mediators formed and inactivated within the same or neighbouring cells prior to their release into circulation as inactive metabolites (15-keto- and 13,14-dihydroketo metabolites). Non-enzymatic peroxidation of arachidonic acid and other fatty acids in vivo can result in prostaglandin-like substances isomeric to the COX-derived prostaglandins that are termed isoprostanes. Prostanoids take part in many physiological and pathophysiological processes in practically every organ, tissue and cell, including the vascular, renal, gastrointestinal and reproductive systems. Their activities are mediated through prostanoid-specific receptors and intracellular signalling pathways, whilst their biosynthesis and action are blocked by nonsteroidal antiinflammatory drugs (NSAID). Isoprostanes are considered to be reliable markers of oxidant stress status and have been linked to inflammation, ischaemia-reperfusion, diabetes, cardiovascular disease, reproductive disorders and diabetes. (PMID: 16986207).
Tetracosapentaenoic acid (24:5n-6)
Tetracosapentaenioc acid is intermediate of Linolenic acid metabolism. [HMDB] Tetracosapentaenioc acid is intermediate of Linolenic acid metabolism.
Tetracosapentaenoic acid (24:5n-3)
Tetracosapentaenioc acid is intermediate of alpha-Linolenic acid metabolism. [HMDB] Tetracosapentaenioc acid is intermediate of alpha-Linolenic acid metabolism.
1-Phenyl-1,3-octadecanedione
1-Phenyl-1,3-octadecanedione is found in fats and oils. 1-Phenyl-1,3-octadecanedione is a constituent of the pollen of Helianthus annuus (sunflower) Constituent of the pollen of Helianthus annuus (sunflower). 1-Phenyl-1,3-octadecanedione is found in fats and oils.
24,25,26,27-Tetranor-23-oxo-hydroxyvitamin D3
This compound belongs to the family of Steroids and Steroid Derivatives. These are compounds based on the cyclopenta[a]phenanthrene carbon skeleton, partially or completely hydrogenated; there are usually methyl groups at C-10 and C-13, and often an alkyl group at C-17. By extension, one or more bond scissions, ring expansions and/or ring contractions of the skeleton may have occurred.
MG(0:0/i-18:0/0:0)
MG(0:0/i-18:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(0:0/i-18:0/0:0) is made up of one 16-methylheptadecanoyl(R2).
Pracinostat
C20H30N4O2 (358.23686399999997)
Testosterone isobutyrate
16,17,18,20-Tetrahydroxy-10,11,14,15-tetrahydronerylgeraniol
(3alpha,14beta)-14,16-epoxy-3,18-[(1-methylethane-1,1,diyl)dioxy]-ent-abieta-7,15(17)-diene-14,16-diol
rel-(2S,4R)-2,4-dimethyl-4-hydroxy-16-phenylhexadecanoic acid 1,4-lactone
(-)-Ochropposinine|10,11-dimethoxy-corynan-17-ol|ochroposinine|Ochropposinin|ochropposinine
Hexadecanoic acid, 2-[(trimethylsilyl)oxy]-, methyl ester
16,17,15,20-tetrahydrosecodin-17-ol|Tetrahydrosecodin-17-ol|Tetrahydrosecodinol
3,17-dimethyl-18,19-dinor-17alpha-cholesta-1,3,5,7,9,11,13-heptaene
(3beta,5beta,14beta)-14,21-epoxy-24-norcholan-20,22-diene-3,5-diol
(3S*,3aR*,5aR*,6S*,8aR*,11bS*,11cS*)-2,3,3a,5,5a,6,7,8,8a,9,10,11c-dodecahydro-5a-(hydroxymethyl)-3-methyl-1,6-methano-1H-azuleno[5,4-g]indole-11b(4H)-propanamide|macropodumine I
2-alpha-acetyloxy-5-alpha-pregn-17(20)-(cis)-en-16-one
(Z)-1-(4-hydroxyphenyl)octadec-13-en-5-one|3,14-Didehydro(Z)-1-(4-Hydroxyphenyl)-5-octadecanone
(3beta,5alpha)-3-Hydroxy-4,4,14-trimethylpregn-8-en-20-one
agallochin C|ent-15-chloro-labd-8(9)-en-3alpha,13,14-triol
C20H35ClO3 (358.22745900000007)
3-[2-butyl-1-[2-(diethylamino)ethyl]-5-benzimidazolyl]-N-hydroxy-2-propenamide
C20H30N4O2 (358.23686399999997)
(9S,10R,13R,14S,17R)-17-((R)-5-hydroxypentan-2-yl)-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one
PGF2alpha-d4
13,14-DIHYDRO PROSTAGLANDIN F1ALPHA
tetranor-23-oxo-1alpha(OH)D3
ascr#21
An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,12R)-12-hydroxytridec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
oscr#21
An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-13-hydroxytridec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
3-stearoyl-sn-glycerol
A 3-acyl-sn-glycerol that has octadecanoyl (stearoyl) as the 3-acyl group.
Butanedioic acid,2-hydroxy-, 1,4-bis(2-ethylhexyl) ester
1-(tert-butyldimethylsilyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine
C19H31BN2O2Si (358.22477359999993)
ALL CIS-7,10,13,16,19-DOCOSAPENTAENOIC ACID ETHYL ESTER
tert-butyl 4-(3-ethyl-3-methyl-2-oxoindol-1-yl)piperidine-1-carboxylate
(1S,2S,3S,4R)-3-[(1S)-1-Amino-2-ethylbutyl]-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-cyclopentanecarboxylic acid methyl ester
C18H34N2O5 (358.24675940000003)
2,2’-(2,5-Dimethyl-1,4-phenylene)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
1,1,5-trimethyl-3,3-bis(2-methylpentan-2-ylperoxy)cyclohexane
1,1,3,3-Tetramethyl-1,3-dioctyldisiloxane
C20H46OSi2 (358.30870259999995)
5-ethyl-2-methylidenenonanoic acid,methyl propanoate,prop-2-enoic acid
3,9-Diazaspiro[5.5]undecane-3-carboxylic acid, 9-benzoyl-, 1,1-dimethylethyl ester
(2E,12R)-12-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]tridec-2-enoic acid
16-Butyl-3-methoxy-estra-1,3,5(10)-triene-16beta,17beta-diol
Silane, [[3,7-dimethyl-9-(2,6,6-trimethyl-2-cyclohexen-1-ylidene)-3,5,7-nonatrienyl]oxy]trimethyl-
C23H38OSi (358.26917779999997)
17beta-Hydroxy-7alpha-methylandrost-4-en-3-one propionate
Pracinostat
C20H30N4O2 (358.23686399999997)
C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
Glycerol 1-octadecanoate
Coating agent, emulsifier, lubricant, texturiser in food processing. It is used in grain products and pastas.
(2E)-13-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]tridec-2-enoic acid
(3-Carboxy-2-tridecanoyloxypropyl)-trimethylazanium
C20H40NO4+ (358.2957180000001)
[3-carboxy-2-[(Z)-3-hydroxydodec-9-enoyl]oxypropyl]-trimethylazanium
C19H36NO5+ (358.25933460000005)
[3-Carboxy-2-(5-methyldodecanoyloxy)propyl]-trimethylazanium
C20H40NO4+ (358.2957180000001)
[3-Carboxy-2-(6-methyldodecanoyloxy)propyl]-trimethylazanium
C20H40NO4+ (358.2957180000001)
[3-Carboxy-2-(3-methyldodecanoyloxy)propyl]-trimethylazanium
C20H40NO4+ (358.2957180000001)
[3-Carboxy-2-(7-methyldodecanoyloxy)propyl]-trimethylazanium
C20H40NO4+ (358.2957180000001)
[3-Carboxy-2-(11-methyldodecanoyloxy)propyl]-trimethylazanium
C20H40NO4+ (358.2957180000001)
[3-Carboxy-2-(8-methyldodecanoyloxy)propyl]-trimethylazanium
C20H40NO4+ (358.2957180000001)
[3-Carboxy-2-(4-methyldodecanoyloxy)propyl]-trimethylazanium
C20H40NO4+ (358.2957180000001)
[3-Carboxy-2-(10-methyldodecanoyloxy)propyl]-trimethylazanium
C20H40NO4+ (358.2957180000001)
[3-Carboxy-2-(9-methyldodecanoyloxy)propyl]-trimethylazanium
C20H40NO4+ (358.2957180000001)
[3-carboxy-2-[(E)-10-carboxydec-6-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-10-carboxydec-2-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-10-carboxydec-7-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-10-carboxydec-8-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-3-hydroxydodec-4-enoyl]oxypropyl]-trimethylazanium
C19H36NO5+ (358.25933460000005)
[3-carboxy-2-[(E)-3-hydroxydodec-6-enoyl]oxypropyl]-trimethylazanium
C19H36NO5+ (358.25933460000005)
[3-carboxy-2-[(E)-3-hydroxydodec-8-enoyl]oxypropyl]-trimethylazanium
C19H36NO5+ (358.25933460000005)
[3-carboxy-2-[(E)-5-hydroxydodec-7-enoyl]oxypropyl]-trimethylazanium
C19H36NO5+ (358.25933460000005)
[3-carboxy-2-[(E)-7-hydroxydodec-9-enoyl]oxypropyl]-trimethylazanium
C19H36NO5+ (358.25933460000005)
[3-carboxy-2-[(E)-8-hydroxydodec-10-enoyl]oxypropyl]-trimethylazanium
C19H36NO5+ (358.25933460000005)
[3-Carboxy-2-(3-oxododecanoyloxy)propyl]-trimethylazanium
C19H36NO5+ (358.25933460000005)
((2,2-Dimethyl-3-vinyl-2H-chromen-7-yl)oxy)triisopropylsilane
Ethyl {(1s,4s,5s)-4-[(isonicotinoylamino)methyl]-5-isopropyl-2-methyl-2-cyclohexen-1-yl}acetate
N-[3-(dimethylamino)propyl]-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
C17H34N4O4 (358.25799240000003)
N-[3-(dimethylamino)propyl]-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
C17H34N4O4 (358.25799240000003)
N-[3-(dimethylamino)propyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
C17H34N4O4 (358.25799240000003)
N-[3-(dimethylamino)propyl]-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
C17H34N4O4 (358.25799240000003)
6,7-dimethoxy-N,N-dipropyl-2-(1-pyrrolidinyl)-4-quinazolinamine
C20H30N4O2 (358.23686399999997)
N-[3-(dimethylamino)propyl]-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
C17H34N4O4 (358.25799240000003)
N-[3-(dimethylamino)propyl]-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
C17H34N4O4 (358.25799240000003)
N-[3-(dimethylamino)propyl]-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
C17H34N4O4 (358.25799240000003)
N-[3-(dimethylamino)propyl]-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[oxo-(propan-2-ylamino)methyl]amino]-2-oxanyl]acetamide
C17H34N4O4 (358.25799240000003)
(3R)-3,21-dihydroxyhenicosanoic acid
A dihydroxy monocarboxylic acid that is 21-hydroxyhenicosanoic acid in which the pro-R hydrogen beta to the carboxy group is replaced by a hydroxy group.
(3R,20R)-3,20-dihydroxyhenicosanoic acid
An (omega-1)-hydroxy fatty acid that is (20R)-20-hydroxyhenicosanoic acid in which the 3-pro-R hydrogen is replaced by a hydroxy group.
[(2R)-3-carboxy-2-tridecanoyloxypropyl]-trimethylazanium
C20H40NO4+ (358.2957180000001)
[(2R)-3-carboxy-2-tridecanoyloxypropyl]-dimethyl-(trideuteriomethyl)azanium
C20H40NO4+ (358.2957180000001)
(1-Hydroxy-3-propanoyloxypropan-2-yl) tetradecanoate
1-Stearoyl-sn-glycerol
A 1-acyl-sn-glycerol that has octadecanoyl (stearoyl) as the 1-acyl group.
1-O-palmityl-2-acetyl-sn-glycerol
A 1-alkyl-2-acetylglycerol in which the 1-alkyl group is specified as palmityl (hexadecyl).
monoacylglycerol 18:0
A monoglyceride in which the acyl group contains a total of 18 carbon atoms and 0 double bonds.
1-acylglycerol 18:0
A 1-monoglyceride in which the acyl group contains 18 carbons and is fully saturated.
2-acylglycerol 18:0
A 2-monoglyceride in which the acyl group contains 18 carbons and is fully saturated.
(9Z,12Z,15Z,18Z,21Z)-Tetracosapentaenoic acid
A very long-chain omega-3 fatty acid that is tetracosanoic acid having five double bonds located at positions 9, 12, 15, 18 and 21 (the (9Z,12Z,15Z,18Z,21Z-isomer).
(6Z,9Z,12Z,15Z,18Z)-Tetracosapentaenoic acid
A very long-chain omega-6 fatty acid that is tetracosanoic acid having five double bonds located at positions 6, 9, 12, 15 and 18 (the 6Z,9Z,12Z,15Z,18Z-isomer).
1-Monostearoylglycerol
A 1-monoglyceride that has stearoyl as the acyl group.
DG(18:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
12-hydroxy-4b,7,7,10a,12a-pentamethyl-3,4,4a,5,6,6a,8,9,10,10b,11,12-dodecahydrochrysene-2-carbaldehyde
4a,6a,7-trimethyl-1h,2h,3h,4h,4bh,5h,6h,6bh,7h,8h,9h,10h,11h,11ah,11bh,12h-indeno[2,1-a]phenanthrene-2,10a-diol
(1s,6r,8s,11s,12r,15s,16s,19s,21s)-19-methoxypentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-ol
(1e,3as,3br,5as,7r,9as,9bs,11as)-1-ethylidene-9a,11a-dimethyl-2-oxo-dodecahydro-3h-cyclopenta[a]phenanthren-7-yl acetate
8-(2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl)-2,6-dimethylocta-3,5-dienoic acid
(1r,5r,6r)-4-ethyl-5-hydroxy-1-[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-7-oxabicyclo[4.1.0]hept-3-en-2-one
(2s,5r,6r,10r,13s,14r)-13-acetyl-2,5,10,14-tetramethyltetracyclo[7.7.0.0²,⁶.0¹⁰,¹⁴]hexadec-1(9)-ene-5-carboxylic acid
16-(dimethylamino)-6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-18-en-7-ol
(1r,3as,3bs,4s,7r,9ar,9bs,11ar)-1-ethenyl-4-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
1,2-o-[2'-hydroxyoctadecyl]-glycerol
{"Ingredient_id": "HBIN000909","Ingredient_name": "1,2-o-[2'-hydroxyoctadecyl]-glycerol","Alias": "NA","Ingredient_formula": "C21H42O4","Ingredient_Smile": "CCCCCCCCCCCCCCCCC(C1OCC(O1)CO)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10547","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1- glycerol monostearate
{"Ingredient_id": "HBIN002550","Ingredient_name": "1- glycerol monostearate","Alias": "NA","Ingredient_formula": "C21H42O4","Ingredient_Smile": "CCCCCCCCCCCCCCCCCC(=O)OCC(CO)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "38883","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1-o-octadecanoyl glycerol
{"Ingredient_id": "HBIN002925","Ingredient_name": "1-o-octadecanoyl glycerol","Alias": "NA","Ingredient_formula": "C21H42O4","Ingredient_Smile": "CCCCCCCCCCCCCCCCCC(=O)OCC(CO)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15941","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-hydroxypregn-17(20)-en-16-one; (3α,5α,17(20)e)-form,ac
{"Ingredient_id": "HBIN008743","Ingredient_name": "3-hydroxypregn-17(20)-en-16-one; (3\u03b1,5\u03b1,17(20)e)-form,ac","Alias": "NA","Ingredient_formula": "C23H34O3","Ingredient_Smile": "NA","Ingredient_weight": "358.51","OB_score": "NA","CAS_id": "166901-88-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8072","PubChem_id": "NA","DrugBank_id": "NA"}
agallochin c
C20H35ClO3 (358.22745900000007)
{"Ingredient_id": "HBIN014804","Ingredient_name": "agallochin c","Alias": "NA","Ingredient_formula": "C20H35ClO3","Ingredient_Smile": "CC1=C(C2(CCC(C(C2CC1)(C)C)O)C)CCC(C)(C(CCl)O)O","Ingredient_weight": "358.9 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "686","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "15543015","DrugBank_id": "NA"}
(4s,6e,8e,10s,11e,14e)-4,6,8,10,12,14-hexamethylheptadeca-6,8,11,14-tetraene-3,5,13-trione
(1r,4r,4ar,8as)-4-[(2s,5r)-5-{2-[(hydroxymethylidene)amino]propan-2-yl}-2-methyloxolan-2-yl]-1-isocyano-1,6-dimethyl-3,4,4a,7,8,8a-hexahydro-2h-naphthalene
1-ethylidene-9a,11a-dimethyl-2-oxo-dodecahydro-3h-cyclopenta[a]phenanthren-7-yl acetate
(1r,3as,3bs,5as,9as,9bs,10r,11ar)-1-ethenyl-9a,11a-dimethyl-7-oxo-tetradecahydrocyclopenta[a]phenanthren-10-yl acetate
(2r,3e,5s)-2-[(1r,11ar)-11a-methyl-1h,2h,10h,11h-cyclopenta[a]phenanthren-1-yl]-5,6-dimethylhept-3-ene
(1r,3as,3br,4s,5as,9as,9bs,11ar)-1-ethenyl-9a,11a-dimethyl-7-oxo-tetradecahydrocyclopenta[a]phenanthren-4-yl acetate
(1s,10s,12s,17r,18r)-4-ethenyl-8,8,13,13,17-pentamethyl-7,9-dioxatetracyclo[8.7.1.0⁵,¹⁸.0¹²,¹⁷]octadec-4-en-3-one
2,4-dimethoxy-6-[3-methyl-5-(1,2,6-trimethylcyclohex-2-en-1-yl)pent-2-en-1-yl]phenol
1-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}ethanone
(4r)-4-[(1r,3as,3bs,7s,9ar,9bs,11ar)-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]pentanal
(2r,3e,5e)-8-[(4as,8as)-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-2,6-dimethylocta-3,5-dienoic acid
(4as,4br,6as,10as,10br,12r,12ar)-12-hydroxy-4b,7,7,10a,12a-pentamethyl-3,4,4a,5,6,6a,8,9,10,10b,11,12-dodecahydrochrysene-2-carbaldehyde
(4s,10s)-4,6,8,10,12,14-hexamethylheptadeca-6,8,11,14-tetraene-3,5,13-trione
1-chloro-5-(6-hydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl)-3-methylpentane-2,3-diol
C20H35ClO3 (358.22745900000007)
1,14,17,17-tetramethyl-6-methylidene-8,16,18-trioxapentacyclo[11.8.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]henicos-10-ene
(15e)-16-(2h-1,3-benzodioxol-5-yl)hexadec-15-en-2-one
(1r,4s,7s,9ar,11ar)-1-ethenyl-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
8-(methoxymethyl)-4,4,6a,11b-tetramethyl-1h,2h,3h,4ah,5h,6h,11h,11ah-cyclohexa[a]fluorene-7,10-diol
1-ethenyl-4-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
(1r,2s,5s,6s,9r,12s,13r,16s)-16-(dimethylamino)-6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-18-en-7-ol
(2s)-1-(hydroxyimino-oxo-λ⁵-azanylidene)heptadecan-2-yl acetate
19-methoxypentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-en-8-ol
5-[(6,8-dimethyl-octahydro-1h-quinolizin-4-yl)methyl]-7-methyl-3,4,6,7,8,8a-hexahydro-2h-quinoline-1-carbaldehyde
(7s,8as)-5-{[(4s,6s,8r,9as)-6,8-dimethyl-octahydro-1h-quinolizin-4-yl]methyl}-7-methyl-3,4,6,7,8,8a-hexahydro-2h-quinoline-1-carbaldehyde
(4as,6as,11ar,11bs)-7-(methoxymethyl)-4,4,6a,11b-tetramethyl-1h,2h,3h,4ah,5h,6h,11h,11ah-cyclohexa[a]fluorene-9,10-diol
(3r,5r)-3,5-dimethyl-5-(12-phenyldodecyl)oxolan-2-one
(1s,2r,5s,7s,10r,11s,14r,15r)-16-ethenyl-10,14-dimethyl-18-oxapentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icos-16-ene-5,7-diol
6-[2-(but-2-en-2-yl)-6-hydroxy-1a,6-dimethyl-octahydronaphtho[1,2-b]oxiren-3-yl]-3-methylhexa-3,5-dien-2-one
1-ethenyl-9a,11a-dimethyl-7-oxo-tetradecahydrocyclopenta[a]phenanthren-10-yl acetate
(1r,3as,3bs,4s,7s,9ar,9bs,11ar)-1-ethenyl-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
(1s)-1-[(2s,4r)-4-(hydroxymethyl)-1,3-dioxolan-2-yl]heptadecan-1-ol
n-[(1r,4r,4ar,8as)-4-[(2s,5r)-5-(2-isocyanopropan-2-yl)-2-methyloxolan-2-yl]-1,6-dimethyl-3,4,4a,7,8,8a-hexahydro-2h-naphthalen-1-yl]carboximidic acid
2-[(2r,3r,12bs)-3-ethyl-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]ethanol
1-[(1s,3ar,5ar,7r,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]ethanone
4-ethenyl-8,8,13,13,17-pentamethyl-7,9-dioxatetracyclo[8.7.1.0⁵,¹⁸.0¹²,¹⁷]octadec-4-en-3-one
(2s,3s)-5-[(4as,6s,8ar)-6-hydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-1-chloro-3-methylpentane-2,3-diol
C20H35ClO3 (358.22745900000007)
(2s,4ar,4bs,6as,6br,7r,10ar,11as,11bs)-4a,6a,7-trimethyl-1h,2h,3h,4h,4bh,5h,6h,6bh,7h,8h,9h,10h,11h,11ah,11bh,12h-indeno[2,1-a]phenanthrene-2,10a-diol
(3e,5e)-6-[(1ar,2r,3s,3as,6s,7ar,7bs)-2-[(2e)-but-2-en-2-yl]-6-hydroxy-1a,6-dimethyl-octahydronaphtho[1,2-b]oxiren-3-yl]-3-methylhexa-3,5-dien-2-one
2,4-dimethoxy-6-[(2e)-3-methyl-5-[(1r,6r)-1,2,6-trimethylcyclohex-2-en-1-yl]pent-2-en-1-yl]phenol
(1r)-1-[(2s,4s)-4-(hydroxymethyl)-1,3-dioxolan-2-yl]heptadecan-1-ol
(3e)-16-(2h-1,3-benzodioxol-5-yl)hexadec-3-en-2-one
(3s)-5-[(4as,6s,8ar)-6-hydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-1-chloro-3-methylpentane-2,3-diol
C20H35ClO3 (358.22745900000007)